Subsequently two small studies in patients with RA also suggest that anti-TNF treatment may increase circulating Th17 cells, but these studies did not directly investigate the relationship of these changes to treatment response [24, 25]. The gene discussed is TNF; the disease is rheumatoid arthritis.